現代牧業(01117.HK)非全資附屬斥1,908萬人幣收購雲養牛科技股權
現代牧業(01117.HK)公布,間接非全資附屬愛養牛科技斥1,908萬元人民幣購買雲養牛科技的全部股權。
交易完成後,雲養牛科技將由買方全資擁有,而買方則分別由現代牧業及內蒙古蒙牛擁有75%及25%。收購事項後,現代牧業於雲養牛科技的權益將由48%增至75%。雲養牛科技將成為集團的間接非全資附屬公司。雲養牛科技的財務業績將綜合併入集團的財務報表。
集團指,收購事項可進一步發揮雲養牛科技與集團的產業鏈協同優勢,並通過集團現有的生態共享平台,提升集團為下游客戶提供農牧業牧場相關信息技術解決方案及AIOT解決方案服務的能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.